Luminex Receives BARDA Contract to Support Development of Second, Rapid SARS-CoV-2 Test
The Aries SARS-CoV-2 assay will run on the company’s Aries system, an FDA-cleared, automated molecular diagnostics platform for moderate-complexity labs.
Read More